Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Israel's total equity for the quarter that ended in Mar. 2026 was ₪21,033 Mil.
This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.
The Israel Total Equity Related Terms
The Israel Total Equity Historical Data
* Premium members only.
The historical data trend for The Israel's Total Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Israel (XTAE:ILCO) has a Total Equity of ₪21,033 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for The Israel and its competitors.
Is The Israel's Total Equity too high?
The Israel's current Total Equity is ₪21,033 Mil. Overall, The Israel has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Israel's Total Equity compare to LIN and SHW?
The Israel's Total Equity of ₪21,033 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Chemicals company?
A good Total Equity depends on the Chemicals industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for The Israel and its competitors. The Israel's current Total Equity is ₪21,033 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Israel stock overvalued right now?
Based on GuruFocus' analysis, The Israel (XTAE:ILCO) is currently considered Modestly Undervalued. The stock's GF Value™ is ₪88.37, compared to a current price of ₪79.54 — trading 10% below its estimated fair value. The current Total Equity is ₪21,033 Mil. The Israel's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For The Israel (XTAE:ILCO), the current Total Equity is ₪21,033 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Israel (XTAE:ILCO) Overvalued in 2026?
Based on GuruFocus' analysis, The Israel stock appears to be undervalued.
The current stock price of ₪79.54 is trading 10% below its estimated GF Value™ of ₪88.37.
GuruFocus considers The Israel to be Modestly Undervalued.
Key valuation signals for XTAE:ILCO:
Total Equity: ₪21,033 Mil
GF Value™: ₪88.37 vs. price of ₪79.54 (10% below fair value)
No single metric tells the full story. See the XTAE:ILCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Israel Corp Ltd is a holding company. Along with its subsidiaries, it operates as a specialty minerals and chemicals company creating solutions to challenges in the food, agriculture, and industrial markets by leveraging its bromine, potash, and phosphate resources. The group operates through the following segments: Industrial Products (Bromine), Potash, Phosphate Solutions, and Growing Solutions. Maximum revenue is generated from its Phosphate Solutions segment, which manufactures phosphoric acid, sulphuric acid, green phosphoric acid, and phosphate fertilizers through its mines and facilities in Israel and China. Geographically, the group generates maximum revenue from Israel, followed by Europe, South America, North America, Asia, and other regions.
65GF Score
Get the complete analysis for XTAE:ILCO
Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:ILCO has been successfully added to your 
